慢阻肺对已确诊心血管疾病患者心血管风险因素及结局的影响
基于加拿大安大略省2008年496 056例已确诊心血管疾病患者的回顾性人群队列,其中69 161例(13.9%)合并慢阻肺,随访至2016年。调整心脏风险因素、共病、社会经济状况等后,合并慢阻肺者主要不良心脏事件发生率更高(HR 1.24,95%CI 1.21-1.26),但接受预防性心血管药物或心内科就诊的比例更低。
要点
- 已确诊心血管疾病者中合并慢阻肺与主要不良心脏事件风险升高相关(HR 1.24)。
- 合并慢阻肺的患者接受预防性心血管药物及心内科就诊的比例更低。
- 需针对性改善慢阻肺人群的心血管二级预防策略。
核心结论
- 在大型真实世界已确诊心血管疾病人群中,慢阻肺与更高的心血管事件发生率相关,但与更低的预防性治疗率相关。
研究设计与样本
- 回顾性人群队列研究,使用加拿大安大略省卫生行政、药物、实验室、电子病历等数据。
- 纳入2008年1月1日有心血管疾病史的496 056例个体,其中69 161例(13.9%)有医生诊断的慢阻肺,随访至2016年。
主要发现
- 合并慢阻肺者主要不良心脏事件发生率为45.3/1000人年,高于单纯心血管疾病者的28.6/1000人年。
- 调整心脏风险因素、共病、社会经济状况等因素后,慢阻肺与主要不良心脏事件的HR为1.24(95%CI 1.21-1.26)。
- 合并慢阻肺者接受预防性心血管药物或心内科就诊的可能性更低。
临床怎么用
- 对已确诊心血管疾病且合并慢阻肺的患者,应关注其心血管事件风险并评估二级预防措施是否到位。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about the association between chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) in people with established CVD. Knowing if COPD is associated with a higher risk of cardiovascular events would guide appropriate secondary prevention. OBJECTIVE: To examine the risk of COPD on major adverse cardiac events (MACEs, acute myocardial infarction, stroke and cardiovascular death) in a complete real-world population of a large province, with known CVD. METHODS: We conducted a retrospective population cohort study using health administration, medication, laboratory, electronic medical record and other data from Ontario, Canada. All people with a history of CVD with and without physician-diagnosed COPD as of 2008 were followed until 2016 and cardiac risk factors, sociodemographic factors, comorbidities and other factors were compared. Sequential cause-specific hazard models adjusting for these factors determined the risk of MACE in people with COPD. RESULTS: Of 496 056 individuals with CVD in Ontario on 1 January 2008, 69 161 (13.9%) had COPD. MACE occurred more frequently among those with CVD (45.3 per 1000 person-years) and COPD compared with those with CVD alone (28.6 per 1000 person-years) (HR 1.24, 95% CI 1.21-1.26) after adjustment for cardiac risk factors, comorbidities, socioeconomic status and other factors. People with COPD were less likely to receive preventive CVD medications or see a cardiologist. CONCLUSION: In a large, real-world population of people with established CVD, COPD was associated with a higher rate of cardiovascular events but a lower rate of preventive therapy. Strategies are needed to improve secondary CVD prevention in the COPD population.
引用
- Cho EE, Maclagan LC, Chu A, et al. Impact of COPD on cardiovascular risk factors and outcomes in people with established cardiovascular disease. Thorax. 2025. PMID: 40032508. doi:10.1136/thorax-2023-220991
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。